Skip to content

The GErman Italian Spanish Takotsubo (GEIST) Registry

The GErman Italian Spanish Takotsubo (GEIST) Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04361994
Acronym
GEIST
Enrollment
500
Registered
2020-04-24
Start date
2015-04-30
Completion date
2035-12-31
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takotsubo Syndrome

Brief summary

GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.

Detailed description

The open-ended, multicenter, international GEIST registry collects data from patients with Takotsubo syndrome during the index hospitalization and follow-up. Furthermore, long-term outcome data are acquired with structured telephone interviews, in case patients do not undergo regular outpatient visits in the participating study centers. The GEIST registry retrospectively includes data, which have already been collected, and prospectively continues to enroll patients with newly diagnosed Takotsubo syndrome.

Interventions

None listed

Sponsors

University of Foggia
CollaboratorOTHER
Prof. Dr. med. Ingo Eitel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with Takotsubo syndrome

Exclusion criteria

* Non

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortalityDay 0All-cause mortality (in-hospital, short-term, long-term)

Secondary

MeasureTime frameDescription
In-Hospital complicationsDay 0Cardiogenic shock, pulmonary edema, death, life-threatening arrhythmias, ventricular thrombus formation, right ventricular involvement

Countries

Germany, Italy

Contacts

Primary ContactIngo Eitel, Prof. Dr.
ingo.eitel@uksh.de004945150044501
Backup ContactThomas Stiermaier, Dr.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026